| Prognostic significance of systolic blood pressure changes during dobutamine-atropine stress technetium-99m sestamibi perfusion scintigraphy in patients with chest pain and known or suspected coronary artery disease. | |
| | |
MedLine Citation:
|
PMID: 9114759 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
To investigate the prognostic value of dobutamine stress-induced changes in systolic blood pressure (BP) 418 patients (mean age 60 years, 238 men) with chest pain and known or suspected coronary artery disease, who underwent a dobutamine-atropine stress technetium-99m sestamibi myocardial perfusion scintigraphic study, were followed up for 25 +/- 15 months. Blood pressure was measured by automatic sphygmomanometry every 3 minutes. A marked decrease and increase in systolic BP from rest to peak were defined as changes of > or = 20 mm Hg, and > or = 30 mm Hg, respectively. Worst outcome events were cardiac death (n = 30), nonfatal myocardial infarction (n = 17), and hospitalization for congestive heart failure (n = 8). A decrease in systolic BP (prevalence 16%) was associated with older age and higher baseline systolic BP. Fixed and reversible sestamibi perfusion defects and follow-up results were similar to patients without a systolic BP decrease. In contrast, an increase in systolic BP (prevalence 24%) was associated with younger age, lower baseline systolic BP, and with absence of a history of prior congestive heart failure or treatment with angiotensin-converting enzyme inhibitors. Furthermore, these patients had fewer fixed perfusion defects and tended to have fewer annual event rates (3.5% vs 7.5%, p < 0.10). In a multivariate model, an increase in systolic BP was not an independent predictor for subsequent events. In conclusion, a dobutamine-induced decrease in systolic BP is not associated with fixed or reversible sestamibi defects or adverse prognosis. An increase in systolic BP, however, is associated with less fixed sestamibi defects and a tendency toward less annual event rates. |
| | |
Authors:
|
M L Geleijnse; A Elhendy; R T van Domburg; R Rambaldi; A E Reijs; J R Roelandt; P M Fioretti |
Related Documents
:
|
1708019 - Hypertension after intersalt: prospects for prevention. 1590099 - The effect of low-dose oral contraceptives and norplant on blood pressure and body weig... 19833299 - Adaptation of heart rate and blood pressure to short and long duration space missions. 9799029 - Effects of potassium supplementation on office, home, and 24-h blood pressure in patien... 8107309 - Pressor effect of recombinant human erythropoietin: results of home blood pressure meas... 6829439 - Predictability of blood pressure response to isometric stress. 17816739 - Interplanetary magnetic field polarity and the size of low-pressure troughs near 180{de... 18283269 - Children and adolescents with obesity and the metabolic syndrome have high circulating ... 9681289 - Inadequate blood pressure control in african hypertensives. who is responsible: patient... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: The American journal of cardiology Volume: 79 ISSN: 0002-9149 ISO Abbreviation: Am. J. Cardiol. Publication Date: 1997 Apr |
Date Detail:
|
Created Date: 1997-05-08 Completed Date: 1997-05-08 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0207277 Medline TA: Am J Cardiol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 1031-5 Citation Subset: AIM; IM |
Affiliation:
|
Thoraxcentre, Rotterdam, The Netherlands. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenergic beta-Agonists
/
diagnostic use* Adult Age Factors Aged Aged, 80 and over Anti-Arrhythmia Agents / therapeutic use Atropine / therapeutic use Blood Pressure / drug effects* Coronary Angiography Coronary Disease / radiography, radionuclide imaging* Dobutamine / diagnostic use* Female Humans Male Middle Aged Prognosis Radiopharmaceuticals / diagnostic use* Systole Technetium Tc 99m Sestamibi / diagnostic use* |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic beta-Agonists; 0/Anti-Arrhythmia Agents; 0/Radiopharmaceuticals; 109581-73-9/Technetium Tc 99m Sestamibi; 34368-04-2/Dobutamine; 51-55-8/Atropine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Additional antianginal and anti-ischemic efficacy of mibefradil in patients pretreated with a beta b...
Next Document: Quantitative evaluation of the segmental left ventricular response to dobutamine stress by tissue Do...